Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (823) Rash
...CenterWatch: Clinical Trials in Category (823) Rash Rash Country • [X]   Canada Canada Montreal, QC : Montreal General Hospital Tolérance et absorption systémique de la ...
View Page

2.  Study Posting (5141) Trial #137092, Rash, Montreal, QC, Canada
...Study Posting (5141) Trial #137092, Rash, Montreal, QC, Canada Trial Information Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash This is a clinical research study of an experimental treatment, Menadione Topical Lotion (Menadione). Menadione ...
View Page

3.  Study Posting (5141) Trial #155965, Rash, St. Louis, MO
...Study Posting (5141) Trial #155965, Rash, St. Louis, MO Trial Information Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash This is a clinical research study of an experimental treatment, Menadione Topical Lotion (Menadione). Menadione ...
View Page

4.  Study Posting (5141) Trial #137091, Rash, Chicago, IL
...Study Posting (5141) Trial #137091, Rash, Chicago, IL Trial Information Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash This is a clinical research study of an experimental treatment, Menadione Topical Lotion (Menadione). Menadione ...
View Page

5.  Study Posting (5141) Trial #155967, Rash, Boston, MA
...Study Posting (5141) Trial #155967, Rash, Boston, MA Trial Information Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash This is a clinical research study of an experimental treatment, Menadione Topical Lotion (Menadione). Menadione ...
View Page

6.  Study Posting (5141) Trial #155969, Rash, Vallejo, CA
...Study Posting (5141) Trial #155969, Rash, Vallejo, CA Trial Information A Phase 1 study of Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash This is a research study of an experimental treatment, Menadione Topical Lotion. (This lotion is ...
View Page

7.  Study Posting (333) Trial #155658, Herpetic Neuralgia, Bingham Farms, MI
...Farms, MI Trial Information Pain after Shingles / Post-Herpetic Neuralgia (PHN) Pain after the shingles rash has healed is very common and can feel like burning, tingling, stabbing pain. We are investigating a treatment for people still experiencing pain at the rash site after the rash has healed. This study requires 8 visits to the clinic and ...
View Page

8.  CenterWatch: Clinical Trials in Category (35) Pancreatic Cancer
...Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer Rosario : Research Site: A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Santa Fe : Research ...
...Erlotinib) in Patients With Advanced Pancreatic Cancer Santa Fe : Research Site: A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Villa Domínico : Research ...
View Page

9.  Study Posting (2975) Trial #140521, Rash, Plano, TX
...Study Posting (2975) Trial #140521, Rash, Plano, TX Trial Information Jock Itch Study If you have been experiencing a rash in the groin area, you might have jock itch, or tinea cruris.  A research study ...
View Page

10.  Study Posting (4519) Trial #133372, Pancreatic Cancer, Southampton, United Kingdom
...Posting (4519) Trial #133372, Pancreatic Cancer, Southampton, United Kingdom Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

11.  Study Posting (4519) Trial #133371, Pancreatic Cancer, London, United Kingdom
...Posting (4519) Trial #133371, Pancreatic Cancer, London, United Kingdom Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

12.  Study Posting (4519) Trial #133382, Pancreatic Cancer, Taipei, Taiwan
...Study Posting (4519) Trial #133382, Pancreatic Cancer, Taipei, Taiwan Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

13.  Study Posting (4519) Trial #133373, Pancreatic Cancer, Madrid, Spain
...Study Posting (4519) Trial #133373, Pancreatic Cancer, Madrid, Spain Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

14.  Study Posting (4519) Trial #133395, Pancreatic Cancer, Girona, Spain
...Study Posting (4519) Trial #133395, Pancreatic Cancer, Girona, Spain Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

15.  Study Posting (4519) Trial #133381, Pancreatic Cancer, Singapore, Singapore
...Study Posting (4519) Trial #133381, Pancreatic Cancer, Singapore, Singapore Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

16.  Study Posting (4519) Trial #133411, Pancreatic Cancer, Sibiu, Romania
...Study Posting (4519) Trial #133411, Pancreatic Cancer, Sibiu, Romania Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

17.  Study Posting (4519) Trial #133408, Pancreatic Cancer, Cluj-Napoca, Romania
...Posting (4519) Trial #133408, Pancreatic Cancer, Cluj-Napoca, Romania Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

18.  Study Posting (4519) Trial #158502, Pancreatic Cancer, Bucharest, Romania
...Study Posting (4519) Trial #158502, Pancreatic Cancer, Bucharest, Romania Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

19.  Study Posting (4519) Trial #158590, Pancreatic Cancer, Brasov, Romania
...Study Posting (4519) Trial #158590, Pancreatic Cancer, Brasov, Romania Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page

20.  Study Posting (4519) Trial #139872, Pancreatic Cancer, Warszawa, Poland
...Study Posting (4519) Trial #139872, Pancreatic Cancer, Warszawa, Poland Trial Information A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer Status: Recruiting Protocol ...
...La Roche Company Division: Pharmaceutical Official Scientific Title: A randomized, open-label, dose-escalation to rash study to assess the effect of Tarceva in combination with gemcitabine on overall survival in ...
View Page